 Amifostine
"Amifostine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
| Descriptor ID |
D004999
|
| MeSH Number(s) |
D02.705.400.625.050 D02.705.539.345.050 D02.886.300.692.050
|
| Concept/Terms |
Amifostine- Amifostine
- Ethiofos
- APAETP
- Gammaphos
- Amifostine Trihydrate
- Trihydrate, Amifostine
Ethyol- Ethyol
- US Bioscience Brand of Amifostine
- Lilly Brand of Amifostine
- Amifostine Lilly Brand
- Schering-Plough Brand of Amifostine
- Amifostine Schering-Plough Brand
- Schering Plough Brand of Amifostine
- Alza Brand of Amifostine
- Amifostine Alza Brand
- Essex Brand of Amifostine
- Amifostine Essex Brand
Amifostine Anhydrous- Amifostine Anhydrous
- Anhydrous, Amifostine
- Ethiofos Anhydrous
- Anhydrous, Ethiofos
- S-(N-(3-Aminopropyl)-2-aminoethyl)thiophosphoric Acid
- Aminopropylaminoethylthiophosphoric Acid
|
Below are MeSH descriptors whose meaning is more general than "Amifostine".
Below are MeSH descriptors whose meaning is more specific than "Amifostine".
This graph shows the total number of publications written about "Amifostine" by people in this website by year, and whether "Amifostine" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 1 | 0 | 1 | | 2000 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Amifostine" by people in Profiles.
-
Preisler HD, Venugopal P, Gregory SA, Hsu W, Loew J, Adler S, Gezer S, Creech S, Galvez A, Slivnick D, Andric T, Larson RA, Jajeh A. Poor prognosis acute myelogenous leukemia: 1 - response to treatment with high dose cytarabine/mitoxantrone/ethyol @ (Amifostine). Leuk Res. 2000 Aug; 24(8):671-80.
-
Raza A, Qawi H, Lisak L, Andric T, Dar S, Andrews C, Venugopal P, Gezer S, Gregory S, Loew J, Robin E, Rifkin S, Hsu WT, Huang RW. Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone. Blood. 2000 Mar 01; 95(5):1580-7.
-
Keshavarzian A, Haydek J, Zabihi R, Doria M, D'Astice M, Sorenson JR. Agents capable of eliminating reactive oxygen species. Catalase, WR-2721, or Cu(II)2(3,5-DIPS)4 decrease experimental colitis. Dig Dis Sci. 1992 Dec; 37(12):1866-73.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|